- A Case of Myocardial Injury after Phenylpropanolamine Ingestion
-
Yoon WC, Yeo DG, Kim HJ, Park JK, Doh JH, Ryu JK, Choi JY, Chang SG
- KMID: 2145673
- Korean Circ J.
- 2000 Mar;30(3):365-368.
- doi: 10.4070/kcj.2000.30.3.365
Phenylpropanolamine is a sympathomimetic amine used widely as a decongestant or appetite suppressant. Reports of the myocardial injury from the use of phenylpropanolamine are rare and the mechanism of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Cerebral Hemorrhage caused by Phenylpropanolamine
-
Yu KH, Lee BR, Kang KS, Ma HI, Jung S, Lee BC
- KMID: 2342889
- J Korean Neurol Assoc.
- 2001 May;19(3):298-301.
Phenylpropanolamine (PPA) is the major ingredient of over-the-counter drugs, including diet pills and nasal decon-gestants. We present a case of ICH induced by PPA in diet pills in a 36-year-old... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Effect of Ornade Spansule in Stress Incontinence
-
Oh JS, Shin DM
- KMID: 1680694
- Korean J Urol.
- 1987 Dec;28(6):901-904.
There were 18 woman with mild to moderate stress incontinence treated with the Sympathomimetic agents, with were combined with phenylpropanolamine hydrochloride, chlorpheniramine maleate, and isopropamide. The majority of these patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Studies on the Association between Phenylpropanolamine (PPA) and Hemorrhagic Stroke in Other Countries
-
Lee SM, Yoon BW, Park BJ
- KMID: 2303914
- Korean J Epidemiol.
- 2004 Dec;26(2):1-7.
OBJECTIVES: Phenylpropanolamine (PPA) had been used widely as cold remedies or appetite suppressants. However, products containing PPA were withdrawn in sequence in the US, Japan, and Korea due to the... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Effects of Amitriptyline on the Nocturia of Patients with Benign Prostatic Hyperplasia
-
You SH, Jeong HJ
- KMID: 2312002
- Korean J Urol.
- 2008 Apr;49(4):343-349.
PURPOSE: We evaluated the effects of amitiptyline, as one of the first-line therapies, on the nocturia of patients with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: Between June 2005 and December... -
- CITED
-
- Close
- SHARE
-
- Close
- Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
-
Jin LH, Park CS, Shin HY, Yoon SM, Lee T
- KMID: 2232806
- Int Neurourol J.
- 2011 Sep;15(3):120-126.
PURPOSE: We investigated bladder function, with a special focus on nonvoiding contractions (NVCs), in awake rats with chronic chemical cystitis and bladder outlet obstruction (BOO) by use of simultaneous registrations... -
- CITED
-
- Close
- SHARE
-
- Close
- Stent Position Is More Important than alpha-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized Study
-
Lee SJ, Yoo C, Oh CY, Lee YS, Cho ST, Lee SH, Yang DY, Lee SK, Cho JS
- KMID: 2314628
- Korean J Urol.
- 2010 Sep;51(9):636-641.
PURPOSE: To evaluate the clinical factors that impact ureteral stent-related lower urinary tract symptoms (LUTS) after ureteroscopic ureterolithotomy, including the stent position and medication. MATERIALS AND METHODS: Fifty-three patients who underwent... -
- CITED
-
- Close
- SHARE
-
- Close
- Characterization of Bladder Selectivity of Antimuscarinic Agents on the Basis of In Vivo Drug-Receptor Binding
-
Yamada S, Kuraoka S, Osano A, Ito Y
- KMID: 2232961
- Int Neurourol J.
- 2012 Sep;16(3):107-115.
The in vivo muscarinic receptor binding of antimuscarinic agents (oxybutynin, solifenacin, tolterodine, and imidafenacin) used to treat urinary dysfunction in patients with overactive bladder is reviewed. Transdermal administration of oxybutynin... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Bladder Training and/or Tolterodine in Female Patients with Overactive Bladder Syndrome: A Prospective, Randomized Study
-
Song C, Park JT, Heo KO, Lee KS, Choo MS
- KMID: 1713119
- J Korean Med Sci.
- 2006 Dec;21(6):1060-1063.
- doi: 10.3346/jkms.2006.21.6.1060
We compared the effects of bladder training and/or tolterodine as first line treatment in female patients with overactive bladder (OAB). One hundred and thirty-nine female patients with OAB were randomized... -
- CITED
-
- Close
- SHARE
-
- Close
